Biosimilar User Fee Revenue Missed Estimates Again In FY 2019, Spending Reduced

 
• By Derrick Gingery
  
Money Wave
Estimates of future BsUFA revenue indicate substantial increases compared to FY 2019 collections. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics